{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:13:06Z","timestamp":1768000386893,"version":"3.49.0"},"reference-count":25,"publisher":"Japan Neurosurgical Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2021]]},"DOI":"10.2176\/nmc.oa.2020-0430","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T22:12:22Z","timestamp":1622499142000},"page":"422-432","source":"Crossref","is-referenced-by-count":9,"title":["Higher Non-fasting Serum Triglyceride Preceding the Carotid Stenosis Progression"],"prefix":"10.2176","volume":"61","author":[{"given":"Yoichi","family":"MIURA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yume","family":"SUZUKI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"KANAMARU","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"SHIBA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"YASUDA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"TOMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"SUZUKI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mie University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Vouillarmet J, Helfre M, Maucort-Boulch D, Riche B, Thivolet C, Grange C: Carotid atherosclerosis progression and cerebrovascular events in patients with diabetes. <i>J Diabetes Complications<\/i> 30: 638\u2013643, 2016","DOI":"10.1016\/j.jdiacomp.2016.01.022"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kitagami M, Yasuda R, Toma N, et al.: Impact of hypertriglyceridemia on carotid stenosis progression under normal low-density lipoprotein cholesterol levels. <i>J Stroke Cerebrovasc Dis<\/i> 26: 1793\u20131800, 2017","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Langsted A, Nordestgaard BG: Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58434 individuals from the Copenhagen General Population Study. <i>Clin Chem<\/i> 57: 482\u2013489, 2011","DOI":"10.1373\/clinchem.2010.157164"},{"key":"4","unstructured":"4) NICE clinical guideline CG181 (2014). Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. https:\/\/www.nice.org.uk\/guidance\/cg181\/evidence\/lipidmodification-update-full-guideline-243786637 (Accessed on 2020 Mar 14)"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Patsch JR, Miesenbock G, Hopferwieser T, et al.: Relation of triglyceride metabolism and coronary artery disease. <i>Arterioscler Thromb<\/i> 12: 1336\u20131345, 1992","DOI":"10.1161\/01.ATV.12.11.1336"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV: Clinical relevance of postprandial lipaemia. <i>Curr Med Chem<\/i> 12: 1931\u20131945, 2005","DOI":"10.2174\/0929867054546609"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A: Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. <i>JAMA<\/i> 298: 299\u2013308, 2007","DOI":"10.1001\/jama.298.3.299"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. <i>JAMA<\/i> 298: 309\u2013316, 2007","DOI":"10.1001\/jama.298.3.309"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG: Nonfasting triglycerides and risk of ischemic stroke in the general population. <i>JAMA<\/i> 300: 2142\u20132152, 2008","DOI":"10.1001\/jama.2008.621"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tanemura H, Maeda M, Ichikawa N, et al.: High-risk plaque for carotid artery stenting evaluated with 3-dimensional T1-weighted gradient echo sequence. <i>Stroke<\/i> 44: 105\u2013110, 2013","DOI":"10.1161\/STROKEAHA.112.663138"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nordestgaard BG, Langsted A, Mora S, et al.: Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. <i>Eur Heart J<\/i> 37: 1944\u20131958, 2016","DOI":"10.1093\/eurheartj\/ehw152"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Miura Y, Suzuki H: Dyslipidemia and atherosclerotic carotid artery stenosis. <i>Vessel Plus<\/i> 3: 1, 2019","DOI":"10.20517\/2574-1209.2018.69"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Peng J, Luo F, Ruan G, Peng R, Li X: Hypertriglyceridemia and atherosclerosis. <i>Lipids Health Dis<\/i> 16: 233, 2017","DOI":"10.1186\/s12944-017-0625-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wang L, Gill R, Pedersen TL, Higgins LJ, Newman JW, Rutledge JC: Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. <i>J Lipid Res<\/i> 50: 204\u2013213, 2009","DOI":"10.1194\/jlr.M700505-JLR200"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Shaikh M, Wootton R, Nordestgaard BG, et al.: Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans. <i>Arterioscler Thromb<\/i> 11: 569\u2013577, 1991","DOI":"10.1161\/01.ATV.11.3.569"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nordestgaard BG, Tybjaerg-Hansen A, Lewis B: Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits: roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants. <i>Arterioscler Thromb<\/i> 12: 6\u201318, 1992","DOI":"10.1161\/01.ATV.12.1.6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Zilversmit DB: Atherogenesis: a postprandial phenomenon, <i>Circulation<\/i> 60: 473\u2013485, 1979","DOI":"10.1161\/01.CIR.60.3.473"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kolovou GD, Anagnostopoulou KK, Daskalopoulou SS, Mikhailidis DP, Cokkinos DV: Clinical relevance of postprandial lipaemia. <i>Curr Med Chem<\/i> 12: 1931\u20131945, 2005","DOI":"10.2174\/0929867054546609"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Welty FK: How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis? <i>Curr Cardiol Rep<\/i> 15: 400, 2013","DOI":"10.1007\/s11886-013-0400-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hennuyer N, Duplan I, Paquet C, et al.: The novel selective PPAR\u03b1 modulator (SPPARM\u03b1) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis. <i>Atherosclerosis<\/i> 249: 200\u2013208, 2016","DOI":"10.1016\/j.atherosclerosis.2016.03.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Lehti S, Nguyen SD, Belevich I, et al.: Extracellular lipids accumulate in human carotid arteries as distinct three-dimensional structures and have proinflammatory properties. <i>Am J Pathol<\/i> 188: 525\u2013538, 2018","DOI":"10.1016\/j.ajpath.2017.09.019"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Moerman AM, Visscher M, Slijkhuis N, et al.: Lipid signature of advanced human carotid atherosclerosis assessed by mass spectrometry imaging. <i>J Lipid Res<\/i> 62: 100020, 2021","DOI":"10.1194\/jlr.RA120000974"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Hu Y, Huang WLR, Zhang X: Postchallenge plasma glucose excursions, carotid intima-media thickness, and risk factors for atherosclerosis in Chinese population with type 2 diabetes. <i>Atherosclerosis<\/i> 210: 302\u2013306, 2010","DOI":"10.1016\/j.atherosclerosis.2009.11.015"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Esposito K, Giugliano D, Nappo F, et al.: Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. <i>Circulation<\/i> 13; 110: 214\u2013219, 2004","DOI":"10.1161\/01.CIR.0000134501.57864.66"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Wang JG, Staessen JA, Li Y, et al.: Carotid intima-media thickness and antihytertensive treatment: a meta-analysis of randomized controlled trials. <i>Stroke<\/i> 37: 1933\u20131940, 2006","DOI":"10.1161\/01.STR.0000227223.90239.13"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/61\/7\/61_oa.2020-0430\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T22:08:19Z","timestamp":1626300499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/61\/7\/61_oa.2020-0430\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2176\/nmc.oa.2020-0430","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"oa.2020-0430"}}